| Literature DB >> 26651598 |
Paul E Croarkin1, Paul A Nakonezny2, Christopher A Wall3, Lauren L Murphy4, Shirlene M Sampson4, Mark A Frye4, John D Port5.
Abstract
Abnormalities in glutamate neurotransmission may have a role in the pathophysiology of adolescent depression. The present pilot study examined changes in cortical glutamine/glutamate ratios in depressed adolescents receiving high-frequency repetitive transcranial magnetic stimulation. Ten adolescents with treatment-refractory major depressive disorder received up to 30 sessions of 10-Hz repetitive transcranial magnetic stimulation at 120% motor threshold with 3000 pulses per session applied to the left dorsolateral prefrontal cortex. Baseline, posttreatment, and 6-month follow-up proton magnetic resonance spectroscopy scans of the anterior cingulate cortex and left dorsolateral prefrontal cortex were collected at 3T with 8-cm(3) voxels. Glutamate metabolites were quantified with 2 distinct proton magnetic resonance spectroscopy sequences in each brain region. After repetitive transcranial magnetic stimulation and at 6 months of follow-up, glutamine/glutamate ratios increased in the anterior cingulate cortex and left dorsolateral prefrontal cortex with both measurements. The increase in the glutamine/glutamate ratio reached statistical significance with the TE-optimized PRESS sequence in the anterior cingulate cortex. Glutamine/glutamate ratios increased in conjunction with depressive symptom improvement. This reached statistical significance with the TE-optimized PRESS sequence in the left dorsolateral prefrontal cortex. High-frequency repetitive transcranial magnetic stimulation applied to the left dorsolateral prefrontal cortex may modulate glutamate neurochemistry in depressed adolescents.Entities:
Keywords: Adolescent depression; Glutamate; Glutamine; Proton magnetic resonance spectroscopy; Repetitive transcranial magnetic stimulation
Mesh:
Substances:
Year: 2015 PMID: 26651598 PMCID: PMC4716879 DOI: 10.1016/j.pscychresns.2015.11.005
Source DB: PubMed Journal: Psychiatry Res Neuroimaging ISSN: 0925-4927 Impact factor: 2.376